Matthew C Winter

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. doi request reprint Bisphosphonates in breast cancer: teaching an old dog new tricks
    Matthew C Winter
    Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK to Top
    Curr Opin Oncol 21:499-506. 2009
  2. doi request reprint Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer--a randomized biomarker pilot study
    Matthew C Winter
    Academic Unit of Clinical Oncology, CR UK YCR Sheffield Cancer Research Centre, Weston Park Hospital, Sheffield, United Kingdom
    Clin Cancer Res 19:2755-65. 2013
  3. doi request reprint Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    M C Winter
    Academic Unit of Clinical Oncology, Section for Cancer, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Sheffield S10 2SJ, UK
    Cancer Treat Rev 34:453-75. 2008
  4. ncbi request reprint Ten years of rituximab in NHL
    Matthew C Winter
    Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, University of Sheffield, UK
    Expert Opin Drug Saf 8:223-35. 2009

Detail Information

Publications4

  1. doi request reprint Bisphosphonates in breast cancer: teaching an old dog new tricks
    Matthew C Winter
    Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK to Top
    Curr Opin Oncol 21:499-506. 2009
    ..However, recent data suggest that bisphosphonate use in breast cancer may provide more than just supportive care and modify the course of the disease by disrupting the metastatic process...
  2. doi request reprint Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer--a randomized biomarker pilot study
    Matthew C Winter
    Academic Unit of Clinical Oncology, CR UK YCR Sheffield Cancer Research Centre, Weston Park Hospital, Sheffield, United Kingdom
    Clin Cancer Res 19:2755-65. 2013
    ..To investigate the short-term biologic effects of neoadjuvant chemotherapy +/- zoledronic acid (ZOL) in invasive breast cancer...
  3. doi request reprint Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    M C Winter
    Academic Unit of Clinical Oncology, Section for Cancer, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Sheffield S10 2SJ, UK
    Cancer Treat Rev 34:453-75. 2008
    ....
  4. ncbi request reprint Ten years of rituximab in NHL
    Matthew C Winter
    Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, University of Sheffield, UK
    Expert Opin Drug Saf 8:223-35. 2009
    ..Rituximab, a chimeric mouse/human monoclonal antibody targeting the pan-B-cell antigenic marker CD20, was the first monoclonal antibody licensed for use in the treatment of cancer...